cardiac hypertrophy_Tg(Myh6-Map2k7)1Jmol/0

http://metadb.riken.jp/0001625IFVBNTgMyh6Map2k71Jmol0TgMyh6Map2k71Jmol

cardiac hypertrophy_Tg(Myh6-Map2k7)1Jmol/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, Jeffery D Molkentin
  http://metadb.riken.jp/db/mgi_rdf/MGI:3851576

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Myh6-Map2k7)1Jmol/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Myh6-Map2k7)1Jmol

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• cardiac hypertrophy
  http://purl.obolibrary.org/obo/MP_0001625

文献

http://purl.org/net/cito/citesAsAuthority

• Robert A. Kaiser, et.al., Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo., The Journal of biological chemistry, 2005, 280
  http://rdf.ncbi.nlm.nih.gov/pubmed/16043490